Susan Giacalone, MSN, BCMAS, MSL-BC
Vice President, Medical Deployment
Expertise:
Susan leads field medical efforts for EVERSANA. As a leader in the life sciences industry, she brings more than 20 years of medical affairs experience across multiple therapeutic areas, including oncology, hepatology and rare diseases, and she has successfully commercialized products in all market phases. Susan’s career has included numerous senior-level positions, and she earned the MSL Society’s U.S. Manager of the Year award in 2020. Susan holds a bachelor’s degree in nursing from West Chester University in Pennsylvania and a Master of Science in nursing from Wayne State University.
Articles by Susan Giacalone, MSN, BCMAS, MSL-BC
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine and advancing patient outcomes. In this new article by Susan Giacalone, she highlights the significant impact MSLs can have on the success trajectory of newly-launched products. The article also includes a case study that demonstrates how a robust medical affairs operation and MSL team helped build a strategic partnership to overcome industry challenges. It further discusses three key elements necessary to establish high-impact Medical Affairs and MSL teams: Strategic Partnership, Cross-Collaboration and Business Acumen. […]
Incorporating Medical Science Liaisons Early and Often Amplifies Impact and Delivers Stronger Patient Outcomes
The distinctly crucial role Medical Science Liaisons (MSLs) play in the healthcare industry helps ensure success for all stakeholders involved in a patient’s treatment journey. MSLs play a significant role in bridging the gap between scientific knowledge and effectively treating patients, and incorporating their expertise early in the commercialization process is key to achieving adequate product awareness and staying abreast of vital advances in various therapeutic areas. In this new article by Susan Giacalone, discover how MSLs provide critical therapeutic-wide education and combine first class clinical and business acumen during prelaunch and throughout a product’s entire life cycle. DOWNLOAD THE ARTICLE BELOW
The New Role of Medical Field Teams and Their Impact on Launch Success
A combination of industry challenges and an influx of complex therapies in the market, have impacted Medical Science Liaisons (MSLs), Clinical Trial Liaisons (CTLs) and Clinical Nurse Educators (CNEs). Susan Giacalone, MSN, BCMAS, MSL-BC, Vice President, Medical Deployment, Joy Morrell, NP, Vice President, Medical Strategy, Beth Giblin, Director, National MSL, explore the modern expectations of medical teams’ scientific and medical exchange, their role in pre-launch activities and their position in driving therapy adoption and ensuring positive patient outcomes post launch. To build a highly functional medical team the right people with substantial knowledge and the proper infrastructure must be in place. EVERSANA provides manufacturers with a ready-to-deploy team with extensive […]